How to Select Pharma Distributors and Commercial Partners for a Biotech or Medtech Launch

A biotech or medtech company rarely has the people, licences and relationships to reach every market alone. That is why so many launches depend on pharma distributors and commercial partners. The choice is hard to reverse. A partner that moves slowly, mishandles compliance or sits on your product can cost a launch its best months. This guide explains the types of partner, the criteria that matter, the deal terms to negotiate and where a business development consultant can help you decide.
Types of Pharma Distributors and Commercial Partners
The word distributor covers several different models. Knowing which one you need is the first decision.
- Wholesale distributors move product from manufacturer to pharmacy or hospital and provide logistics, storage and invoicing.
- Specialty distributors handle high-cost, temperature-controlled or restricted products and often add patient support.
- Exclusive regional distributors hold the rights to sell in a country or region, often managing registration, pricing and promotion.
- Co-promotion and commercial partners share sales and marketing effort, usually with a larger company's field team.
- Contract sales and commercial organisations supply people and infrastructure while you keep the rights.
Each model changes how much control you keep, how much margin you give up and how much work the partner does for you.
Decide What You Need Before You Search
Start with your own plan, not the partner list. Define the markets, the patients, the timing and the capabilities you lack.
Questions to settle first
- Which markets will you serve directly, and which through partners?
- Does the product need cold chain, special handling or patient programmes?
- Who will own registration, pricing and reimbursement locally?
- How much control over message and brand do you need to keep?
A written brief makes every conversation sharper and lets you compare candidates on equal terms.
Eight Criteria for Comparing Pharma Distributors
Use the same scorecard for every candidate. The following criteria most often separate strong partners from weak ones.
- Market coverage: reach across target hospitals, pharmacies and prescribers
- Therapeutic experience: a record in your disease area and with similar products
- Regulatory and quality standing: licences, audit history and Good Distribution Practice compliance
- Cold chain and logistics: validated storage, transport and traceability
- Market access capability: experience with pricing, tenders and reimbursement
- Commercial focus: whether your product will get attention beside larger brands
- Financial strength: ability to hold inventory and pay on time
- Reputation: references from other manufacturers, ideally ones you can speak to directly
Weight each criterion to suit your product. A rare disease therapy may rank market access and patient support above sheer coverage, while a device may put training and service first.
Due Diligence: What to Check Before You Sign
Promises in a pitch are not proof. Ask for evidence and check it independently.
- Copies of licences and recent inspection or audit outcomes
- Quality procedures for storage, temperature excursions and recalls
- A list of products in the portfolio that compete or conflict with yours
- Reference calls with at least two current or former principals
- Sales performance on comparable launches, with timelines
A good partner welcomes this scrutiny. Resistance is itself information.
Deal Terms That Shape the Partnership
The contract decides who holds the power when things go wrong. Terms to negotiate include:
- Exclusivity: Territory, products and duration, with clear limits
- Minimum performance: Sales or activity targets, with rights to end or convert exclusivity if missed
- Pricing and margin: Transfer price, distributor margin and price change rules
- Data sharing: Sales, stock and market data you receive, and how often
- Regulatory ownership: Who holds licences and files variations
- Exit: Notice, stock buy-back, transition support and handover of records
Build performance conditions in from the start. Exclusivity without minimum targets leaves you tied to a partner who may not deliver.
Common Mistakes in Partner Selection
- Choosing on the highest advance or the lowest margin alone
- Granting wide exclusivity before a partner has proved itself
- Ignoring portfolio conflicts with competing products
- Leaving data rights vague, then flying blind after launch
- Skipping an exit plan until a problem appears
The pattern behind most of these mistakes is speed. Partner decisions made under launch pressure favour the partner who offers certainty fastest, not the one best suited to the product.
How a Business Development Consultant Can Help
A business development consultant can add capacity and perspective to a partner search. The role usually covers building the target list, approaching partners, structuring the process, comparing offers and supporting negotiation. Outside help is most useful when the team lacks time, has not done similar deals or needs an independent view of the trade-offs.
When selecting a consultant, look for life sciences deal experience, clear scope and fee terms, and transparency about any relationships that could affect advice. This work often sits alongside licensing decisions, which we cover in our article on in-licensing for biotech companies.
How Illumination Strategy Supports Partner Selection
Illumination Strategy works with life sciences companies on the partnership decisions that shape a launch. We help teams define what they need, build the partner shortlist, compare options on a clear scorecard and structure distribution and co-promotion deals that the company can live with. Our business development work is led by senior people who have seen deals from both the scientific and commercial side. Learn more on our Business Development & In-Licensing page.
If a launch or a new market is on your horizon, the best time to choose a partner is before the clock starts running. Speak with our team and we will help you see which choices are solid and which need more work.
Frequently Asked Questions
What do pharma distributors do?
Pharma distributors store, transport and deliver medicines or devices to pharmacies, hospitals and clinics. Some also handle registration, pricing, promotion and patient support.
How do I choose a pharma distributor for my product?
Define your needs, then compare candidates on the same scorecard covering coverage, therapeutic experience, compliance, cold chain, market access skill and financial strength. Check references independently.
Should I grant exclusive distribution rights?
Only with clear limits. Tie exclusivity to a territory, a time period and minimum performance targets, and keep rights to end or narrow it if targets are missed.
What is the difference between a distributor and a co-promotion partner?
A distributor mainly buys and moves product, and may add local promotion. A co-promotion partner shares sales and marketing effort, often alongside your own brand.
When should a company start looking for partners?
Well before launch. Partner searches, due diligence and contract negotiation commonly take many months, and registration in some markets takes longer still.
What does a business development consultant do?
A business development consultant helps identify and approach partners, run the selection process, structure the deal and support negotiation, filling gaps in a company's time and experience.
Conclusion
The right partner can open markets that a small team could never reach alone, and the wrong one can stall a launch for years. Know the model you need, score candidates on the same criteria, verify claims and negotiate performance conditions and an exit before you sign. If you want an independent view, a business development consultant can bring structure and pace to the search. For related reading, see our guide to commercial strategy decisions before a product launch.

With nearly 30 years of life sciences leadership experience, Tim Glennon helps founders, executives, and investors navigate critical growth stages through commercialization strategy, market access, and scalable business planning.
Key Takeaways
- Wholesale, specialty, exclusive regional, co-promotion and contract sales partners each trade control for reach differently.
- Write a brief of markets, handling needs and ownership of registration and pricing before you search.
- Score every candidate on the same eight criteria, from coverage and compliance to cold chain and reputation.
- Verify licences, audits, portfolio conflicts and references before you sign.
- Tie exclusivity to minimum performance targets, and agree data rights and an exit plan up front.
More Insights
See how we’ve helped organizations achieve measurable commercialization success across industries.

How to Select Pharma Distributors and Commercial Partners for a Biotech or Medtech Launch
Choosing pharma distributors shapes your launch. Use this guide to compare partners on coverage, compliance, cold chain and deal terms before you sign.

Business Transformation Consulting for Life Sciences: Resetting Commercial Strategy After a Funding Shift or Clinical Readout
Business transformation consulting helps life sciences teams reset commercial strategy after a trial result or funding gap. See the steps that work.

Business Growth Consulting: How to Identify the Right Growth Opportunity Before Investing Resources
How life sciences companies can use business growth consulting to assess markets, rivals and resources before investing. Read Illumination Strategy's guide.

Corporate Development in Biopharma: How to Evaluate Licensing, Acquisition, and Partnership Opportunities
Learn how corporate development teams evaluate biopharma licensing, acquisitions and partnerships, from deal structure to commercial fit. Read the guide.
.png)
.png)
